| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/17/2005 | US20050038036 Treatment of bipolar disorders and associated symptoms |
| 02/17/2005 | US20050038034 Analgesics; neurodegenerative disorders; multiple sclerosis; Parkinson's disease; neuropathic pain |
| 02/17/2005 | US20050038032 Quinoxaline compounds |
| 02/17/2005 | US20050038028 Hydroxyethylene compounds with asp2 inhibitory activity |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038019 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 02/17/2005 | US20050038015 Partial dopamine-D 2 receptor agonist plus serotonin and/oder noradrenaline inhibitor activity |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050038013 Treatment of sleep disorders with cholinesterase inhibitors |
| 02/17/2005 | US20050038011 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
| 02/17/2005 | US20050038010 Substituted heterocyclic compounds and methods of use |
| 02/17/2005 | US20050037984 Administering protein kinase C activator |
| 02/17/2005 | US20050037954 Novel agents for ameliorating motor disorder |
| 02/17/2005 | US20050037495 Human CNS cell lines and methods of use therefor |
| 02/17/2005 | US20050037494 Using antisense agents to reduce and/or prevention genic expression associated with cardi-vascular complications; gene therapy |
| 02/17/2005 | US20050037449 Agent for controlling circadian rhythm disorder |
| 02/17/2005 | US20050037376 Sulfatase polypeptide for use in treatment and prevention of microbial infection, cell proliferative, neurodegenerative and cardiovascular disorders |
| 02/17/2005 | US20050037091 Composition comprising paracetamol and a bitterness masking component |
| 02/17/2005 | US20050037077 Absorption in upper part of gastrointestinal system; microcapsules coated with hydrophilic polymer such as Eudragit |
| 02/17/2005 | US20050037069 Solid and stable creatine/citric acid composition(s) and compositions carbohydrate(s) or hydrates thereof, method for the production and use thereof |
| 02/17/2005 | US20050037026 such as Alzheimer's disease; amyloid precursor proteins; comprises diphtheria toxoid as carrier |
| 02/17/2005 | US20050037009 Methods and reagents for protease inhibition |
| 02/17/2005 | US20050037003 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 02/17/2005 | US20050036985 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/17/2005 | US20050035267 Furnace mount and method of installation |
| 02/17/2005 | US20050035266 Furnace Mount and Method of Installation |
| 02/17/2005 | CA2554566A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/17/2005 | CA2535260A1 Method for treating cachexia with retinoid ligands |
| 02/17/2005 | CA2535249A1 Spiro-substituted tetrahydroquinazolines as corticotropin releasing factor (cfr) antagonists |
| 02/17/2005 | CA2535125A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2535066A1 Macrophage activation inhibitor |
| 02/17/2005 | CA2534899A1 Polypeptides having brain-localizing activity and uses thereof |
| 02/17/2005 | CA2534898A1 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 02/17/2005 | CA2534868A1 Compounds for the treatment of demyelinating and autoimmune diseases |
| 02/17/2005 | CA2534785A1 Tetrahydroquinazoline derivatives as cfr antagonists |
| 02/17/2005 | CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | CA2534528A1 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparationand use as modulators of apoptosis |
| 02/17/2005 | CA2534496A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2534471A1 Method and apparatus for producing ultrafine drug particles |
| 02/17/2005 | CA2534240A1 Treatment for alzheimer's disease and related conditions |
| 02/17/2005 | CA2534057A1 Novel gamma-secretase inhibitors |
| 02/17/2005 | CA2533996A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 02/17/2005 | CA2533174A1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 02/17/2005 | CA2532821A1 Use of human growth hormone in multiple system atrophy |
| 02/17/2005 | CA2532759A1 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 02/17/2005 | CA2532431A1 "7-substituted 3-nitro-pyrazolo [1,5-a] pyrimidines" |
| 02/16/2005 | EP1506999A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 02/16/2005 | EP1506970A1 Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same |
| 02/16/2005 | EP1506967A1 Dipeptidyl peptidase inhibitors |
| 02/16/2005 | EP1506951A1 Preparation and application of transhintotalphenolic acid |
| 02/16/2005 | EP1506776A1 Use of enzyme inhibitors of the dipeptidylpeptidase IV and/or of the aminopeptidase n , and pharmaceutical preparations thereof for the prevention or therapy of neurodegenerative diseases |
| 02/16/2005 | EP1506400A2 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor |
| 02/16/2005 | EP1506285A2 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 02/16/2005 | EP1506232A1 Sodium channel regulators and modulators |
| 02/16/2005 | EP1506228A2 Role of p62 in aging-related disease |
| 02/16/2005 | EP1506215A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 02/16/2005 | EP1506212A2 Novel substituted sulfamate anticonvulsant derivatives |
| 02/16/2005 | EP1506211A1 C-aryl glucoside sglt2 inhibitors and method |
| 02/16/2005 | EP1506205A2 Novel azacyclic ethynyl derivatives |
| 02/16/2005 | EP1506200A2 Novel diazabicyclic biaryl derivatives |
| 02/16/2005 | EP1506196A2 Pyrazolopyrimidines |
| 02/16/2005 | EP1506194A1 SUBSTITUTED RING-FUSED IMIDAZOLE DERIVATES: GABA sb A /sb RECEPTOR LIGANDS |
| 02/16/2005 | EP1506193A1 Carbamate-substituted pyrazolopyridines |
| 02/16/2005 | EP1506192A1 Substituted pyrroline kinase inhibitors |
| 02/16/2005 | EP1506191A1 Benzoxazine and benzoxazinone substituted triazoles |
| 02/16/2005 | EP1506190A1 (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker |
| 02/16/2005 | EP1506187A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 02/16/2005 | EP1506186A1 Substituted heterocyclic compounds and methods of use |
| 02/16/2005 | EP1506185A1 Novel compounds and their use |
| 02/16/2005 | EP1506180A1 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 02/16/2005 | EP1506179A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| 02/16/2005 | EP1506178A2 Bicyclic modulators of androgen receptor function |
| 02/16/2005 | EP1506176A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/16/2005 | EP1506174A2 Opioid and opioid-like compounds and uses thereof |
| 02/16/2005 | EP1506167A1 Hydroxy tetrahydro-naphthalenylurea derivatives |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1506011A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/16/2005 | EP1506004A2 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac |
| 02/16/2005 | EP1506002A2 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
| 02/16/2005 | EP1505994A1 Novel use of the extract of processed ginseng and saponin isolated therefrom |
| 02/16/2005 | EP1505992A1 Method for reducing pain using oncolytic viruses |
| 02/16/2005 | EP1505984A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 02/16/2005 | EP1505982A1 Trimegestone and estrogens for treating post menopausal disorders |
| 02/16/2005 | EP1505979A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles |
| 02/16/2005 | EP1505976A1 Synergistic combination of an opioid analgesic and a nsaid |
| 02/16/2005 | EP1505974A2 Use of compounds that are effective as selective opiate receptor modulators |
| 02/16/2005 | EP1505973A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/16/2005 | EP1505971A2 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1505962A2 Monotherapy for the treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s) |
| 02/16/2005 | EP1505956A1 A method to improve surface properties of pharmaceutical tablets |
| 02/16/2005 | EP1397365B1 Heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | EP1296698A4 Therapeutic agents - ii |
| 02/16/2005 | EP1296697A4 Therapeutic agents - i |
| 02/16/2005 | EP1281709B1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/16/2005 | EP1267849B1 Restricting reinstatement of drug use |
| 02/16/2005 | EP1253917B1 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 02/16/2005 | EP1246814B1 Compounds and methods for modulation of estrogen receptors |
| 02/16/2005 | EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |